Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Deli Liu, Jonathan E. Shoag, Daniel Poliak, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease
Renee E. Vickman, LaTayia Aaron-Brooks, Renyuan Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
Saheed Oluwasina Oseni, Corey Naar, Mirjana Pavlović, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3110-3110
Open Access | Times Cited: 27
Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 8
Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK/JNK Pathway in Hyperplastic Prostate
Huan Liu, Yongying Zhou, Zhen Wang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer
Mateusz Wylaź, A. Kaczmarská, Dawid Pajor, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115676-115676
Open Access | Times Cited: 17
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance
Renjie Jin, Connor M. Forbes, Nicole L. Miller, et al.
The Prostate (2024) Vol. 84, Iss. 5, pp. 441-459
Closed Access | Times Cited: 6
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia
Tiewen Li, Yu Zhang, Zeng Zhou, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Aging of the progenitor cells that initiate prostate cancer
Jack Freeland, Preston D. Crowell, Jenna M. Giafaglione, et al.
Cancer Letters (2021) Vol. 515, pp. 28-35
Open Access | Times Cited: 30
Epigenetic reprogramming during prostate cancer progression: A perspective from development
Sakshi Goel, Vipul Bhatia, Tanay Biswas, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 136-151
Open Access | Times Cited: 28
METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner
Jiaren Li, Hanyu Yao, Jin Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 19
A step forward in enhancing the health-promoting properties of whole tomato as a functional food to lower the impact of non-communicable diseases
Pier Giorgio Natali, Mauro Piantelli, Alessandra Sottini, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
Teow J. Phua
Medicines (2021) Vol. 8, Iss. 6, pp. 30-30
Open Access | Times Cited: 25
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
Pier Giorgio Natali, Mauro Piantelli, Marco Minacori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5795-5795
Open Access | Times Cited: 7
Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?
Jolanta Guz, Ewelina Zarakowska, Paweł Mijewski, et al.
Cellular Physiology and Biochemistry (2023) Vol. 57, Iss. 4, pp. 200-211
Open Access | Times Cited: 7
The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy
G Xu, Guoyu Dai, Zhongli Huang, et al.
Research and Reports in Urology (2024) Vol. Volume 16, pp. 205-214
Open Access | Times Cited: 2
Estimation of the Prostate Volume from Abdominal Ultrasound Images by Image-Patch Voting
Nur Banu Albayrak, Yusuf Sinan Akgül
Applied Sciences (2022) Vol. 12, Iss. 3, pp. 1390-1390
Open Access | Times Cited: 11
Single‐cell RNA‐sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone
Qiuxia Yan, Miao Wang, Haoran Xia, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 11
Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects
Haifa Almukadi, Basma G. Eid, Rasheed A. Shaik, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112199-112199
Open Access | Times Cited: 14
A Systemic Review and Meta-analysis of Transabdominal Intravesical Prostatic Protrusion Assessment in Determining Bladder Outlet Obstruction and Unsuccessful Trial Without Catheter
Yu Guang Tan, Jonathan Shunming Teo, Tricia Li Chuen Kuo, et al.
European Urology Focus (2021) Vol. 8, Iss. 4, pp. 1003-1014
Closed Access | Times Cited: 12
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients
Renjie Jin, Connor M. Forbes, Nicole L. Miller, et al.
The Prostate (2022) Vol. 82, Iss. 14, pp. 1378-1388
Open Access | Times Cited: 8
Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine
Gabriela Reolon Passos, Mariana G. de Oliveira, Ana Carolina Ghezzi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment
Ali Hashemi Gheinani, Jina Kim, Sungyong You, et al.
Nature Reviews Urology (2023) Vol. 21, Iss. 4, pp. 214-242
Closed Access | Times Cited: 4
Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
Young‐Jin Choi, Meiqi Fan, Nishala Erandi Wedamulla, et al.
Deleted Journal (2023) Vol. 13, Iss. 3, pp. 1698-1710
Open Access | Times Cited: 4
Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2
Christina Sharkey, Xingbo Long, Ra'ad Al‐Faouri, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 3, pp. 300-314
Closed Access | Times Cited: 1
Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
Ken Batai, Michael C. Phung, Robert Bell, et al.
BMC Urology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top